60
Participants
Start Date
September 1, 2020
Primary Completion Date
December 1, 2025
Study Completion Date
July 6, 2026
ZZ06
"The phase I 3 + 3 study design was used in dose escalation from low dose to high dose to determine the MTD.Sequential assignment of Patient cohorts to one of five dose levels of ZZ06 : 0.03mg/kg,0.06mg/kg,0.12mg/kg,0.22mg/kg,0.39mg/kg,0.70mg/kg,1 mg/kg."
NOT_YET_RECRUITING
Jilin Cancer Hospital, Changchun
RECRUITING
The first Bethune hospital of Jilin University, Changchun
RECRUITING
Cedars Sinai Medical Center, Los Angeles
RECRUITING
Montefiore Medical Center, The Bronx
RECRUITING
Kansas University Cancer Center, Fairway
Collaborators (1)
Covance
INDUSTRY
Changchun Intellicrown Pharmaceutical Co. LTD
INDUSTRY